Bryce Point Capital LLC Makes New Investment in DocuSign, Inc. (NASDAQ:DOCU)

Bryce Point Capital LLC purchased a new position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 19,926 shares of the company's stock, valued at approximately $1,792,000. DocuSign accounts for approximately 0.5% of Bryce Point Capital LLC's holdings, making the stock its 24th biggest position.

Several other institutional investors also recently modified their holdings of DOCU. Massachusetts Financial Services Co. MA boosted its stake in DocuSign by 633.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 237,442 shares of the company's stock valued at $21,356,000 after acquiring an additional 205,051 shares during the last quarter. Geode Capital Management LLC lifted its stake in DocuSign by 7.2% in the fourth quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock valued at $335,147,000 after buying an additional 249,179 shares during the period. HighPoint Advisor Group LLC bought a new position in DocuSign during the fourth quarter worth about $229,000. B. Metzler seel. Sohn & Co. AG grew its position in shares of DocuSign by 72.7% during the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 8,677 shares of the company's stock worth $780,000 after buying an additional 3,652 shares during the period. Finally, Alliancebernstein L.P. increased its stake in shares of DocuSign by 70.4% in the 4th quarter. Alliancebernstein L.P. now owns 378,780 shares of the company's stock valued at $34,067,000 after acquiring an additional 156,518 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Remove Ads

Insider Transactions at DocuSign

In other news, insider Robert Chatwani sold 15,706 shares of DocuSign stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the completion of the transaction, the insider now directly owns 76,842 shares in the company, valued at approximately $6,392,485.98. The trade was a 16.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the sale, the director now owns 8,270 shares in the company, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 57,851 shares of company stock worth $4,911,319 in the last ninety days. Insiders own 1.66% of the company's stock.

DocuSign Price Performance

NASDAQ:DOCU traded down $5.16 on Friday, hitting $72.21. 2,881,620 shares of the company's stock were exchanged, compared to its average volume of 2,695,162. The firm has a 50-day moving average price of $86.02 and a 200-day moving average price of $81.98. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company has a market cap of $14.62 billion, a P/E ratio of 14.89, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company had revenue of $776.25 million for the quarter, compared to analysts' expectations of $760.94 million. During the same quarter in the prior year, the business posted $0.76 EPS. The business's revenue was up 9.0% compared to the same quarter last year. On average, research analysts expect that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. Robert W. Baird set a $93.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Needham & Company LLC reissued a "hold" rating on shares of DocuSign in a report on Friday, March 14th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a report on Friday, December 6th. Morgan Stanley increased their price target on DocuSign from $62.00 to $97.00 and gave the stock an "equal weight" rating in a report on Friday, December 6th. Finally, HSBC reiterated a "reduce" rating on shares of DocuSign in a research report on Friday, December 6th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $95.83.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.